From: The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
Model input | Base case value | SA range for one-way sensitivity analyses | Source |
---|---|---|---|
Probability | |||
Hospitalization | 0,26 | 0,01-0,41 | [12] |
PICU, given hospitalization | 0,07 | 0,06-0,18 | [12] |
Mortality, given PICU admission | 0,009 | 0,00–0,06 | [13] |
Acute complications, given hospitalization | 0,13 | 0,10–0,20 | [14] |
Acute complications, given PICU admission | 0,15 | 0,15-0,53 | [15] |
Utility | |||
No hospitalization | 0,95 | 1,00–0,76 | |
Hospitalization without acute complications | 0,88 | 1,00–0,70 | |
Hospitalization with acute complications | 0,59 | 0,70–0,47 | |
PICU without acute complications | 0,73 | 0,87-0,58 | |
PICU with acute complications | 0,51 | 0,60–0,40 | |
HS effectiveness | |||
Reduction of hospitalization | 0,80 | 0,67-0,96 | [11] |
Reduction of LOS | -0,55 | -0,15-0,96 | [11] |